🇸🇬 Kyprolis in Singapore

Kyprolis (carfilzomib) regulatory status in Singapore.

Marketing authorisation

HSA

  • Status: likely_approved

Kyprolis in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Singapore

Frequently asked questions

Is Kyprolis approved in Singapore?

Yes. HSA has authorised it.

Who is the marketing authorisation holder for Kyprolis in Singapore?

Amgen is the originator. The local marketing authorisation holder may differ — check the official source linked above.